Screening Ghanaian Natural Product Extracts for Human African Trypanosomiasis (HAT) and Schistosomiasis Drug Discovery

Status
On going
Start date
Start stage
Screening
Disease
Schistosomiasis
Human African trypanosomiasis (HAT)
Research areas
Drug

Dr. Edmund Ekuadzi, a former Novartis Next Generation Scientist (NGS) Program Fellow at Kwame Nkrumah University of Science and Technology (KNUST) in Ghana, has identified and purified a series of natural product extracts from Ghanaian plants for drug development purposes. Dr. Ekuadzi has shared a set of extracts with Dr. Conor Caffrey at University of California, San Diego (UCSD) to screen for human African trypanosomiasis (HAT) and schistosomiasis drug discovery.